Our Board of Directors

Mary Jane Dykeman is managing partner at INQ Law. In addition to data law, she is a long-standing health lawyer. Her data practice focuses on privacy, artificial intelligence (AI), cyber preparedness and response, and data strategy/governance.  In her health law practice, Mary Jane focuses on clinical and enterprise risk, privacy and information management, governance, corporate/commercial and more. She is currently interim VP Legal/Risk to the Centre for Addiction and Mental Health; and was instrumental in the development of Ontario’s health privacy legislation. Mary Jane regularly consults on large data initiatives and use of data for health research, quality purposes and advanced analytics. She is deputy chair of the Canadian Blood Services Research Ethics Board; sits on the data governance and advisory committees of T-CAIREM, the Temerty Centre for Artificial Intelligence Research and Education in Medicine at the University of Toronto; and is past chair, Alzheimer Society Toronto.

Dr. Sadikovic holds the prestigious position of London Health Sciences Research Chair in Clinical Genomics and Epigenomics and is a Professor in the Department of Pathology and Laboratory Medicine, as well as the Department of Pediatrics at Western University. He is also the Scientific and Clinical Director of the Verspeeten Clinical Genome Centre at London Health Sciences, where he spearheads both clinical and translational genomics research focused on the development of genomic and epigenomic biomarkers and diagnostic technologies for rare, complex, and oncological disorders. In his clinical capacity, Dr. Sadikovic serves as the Program Head of the Molecular Diagnostics Program, overseeing the clinical molecular diagnostics laboratories at the London Health Sciences Centre. He completed his PhD at Western University, followed by a Canadian Cancer Society Postdoctoral Fellowship at Princess Margaret and SickKids Hospitals. His clinical training includes ABMG Clinical Molecular Genetics and Clinical Cytogenetics Fellowships at Baylor College of Medicine. Dr. Sadikovic is the inventor of the EpiSign technology and a leading principal investigator in numerous national and international studies focusing on the development and application of epigenomic biomarkers in rare diseases and other medical areas.

Josh Clark , CA CPA, is a seasoned finance professional with over 20+ years of experience, currently serving at London Health Sciences, one of Canada’s largest teaching hospitals. As a Chartered Professional Accountant, Josh has built a career focused on strategic planning, treasury management, capital allocation, and operational excellence. He is passionate about aligning financial strategy with organizational goals to drive sustainable growth and performance.

In addition to his professional role, Josh currently serves as the Chair of the Finance and Audit Committee and Board member at the London Community Foundation, where he supports initiatives that strengthen the local community.